Prescription Drug Comparative Effectiveness Act of 2002

Summary

Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 23 May 2002

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 23 May 2002

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 23 May 2002

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.